4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.

      Expert review of pharmacoeconomics & outcomes research

      Informa UK Ltd.

      stage III colon cancer, Thailand, adjuvant chemotherapy, cost-utility analysis, oxaliplatin

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection.

          Related collections

          Author and article information

          Journal
          25327502
          10.1586/14737167.2015.972379

          Comments

          Comment on this article